Is elective neck dissection justified in cT2N0M0 oral cavity cancer defined according to the AJCC eighth edition staging system?
Tsung-Ming ChenShyuang-Der TerngLi-Yu LeeShu-Ru LeeShu-Hang NgChung-Jan KangJin-Ching LinChih-Yen ChienChun-Hung HuaCheng Ping WangWen-Cheng ChenYao-Te TsaiChi-Ying TsaiChien-Yu LinKang-Hsing FanHung-Ming WangJason Chia-Hsun HsiehChih-Hua YehChih-Hung LinChung-Kan TsaoNai-Ming ChengTuan-Jen FangShiang-Fu HuangLi-Ang LeeKu-Hao FangYu-Chien WangWan-Ni LinLi-Jen HsinTzu-Chen YenYu-Wen WenChih-Hung LinPublished in: Cancer medicine (2024)
By implementing risk stratification within the NO group, we found that 26% (251/979) of low-risk patients achieved outcomes similar to those in the END group. Therefore, when making decisions regarding the implementation of END in patients with cT2N0M0 OCSCC, factors such as DOI and tumor differentiation should be taken into account.
Keyphrases
- end stage renal disease
- computed tomography
- image quality
- newly diagnosed
- contrast enhanced
- chronic kidney disease
- dual energy
- healthcare
- papillary thyroid
- magnetic resonance imaging
- peritoneal dialysis
- lymph node
- prognostic factors
- positron emission tomography
- patients undergoing
- squamous cell carcinoma
- type diabetes
- magnetic resonance
- pet ct
- skeletal muscle